DEBx Medical

✨ 𝗜𝗻𝘀𝗶𝗱𝗲 𝗲𝘃𝗲𝗿𝘆 𝗯𝗼𝘁𝘁𝗹𝗲 𝗼𝗳 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠®, 𝗮 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗵𝗲𝗮𝗹𝗶𝗻𝗴 𝗯𝗲𝗴𝗶𝗻𝘀. ✨ From eliminating biofilm to effective wound bed preparation, 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠® 𝗶𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗷𝘂𝘀𝘁 𝗮 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁—it's a powerful tool that helps clinicians do what they do best: deliver healing. 🔬 Backed by science, designed for care, and trusted by professionals worldwide. Discover the science behind the solution. 𝗟𝗲𝗮𝗿𝗻 𝗵𝗼𝘄 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠® 𝗶𝘀 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝘄𝗼𝘂𝗻𝗱 𝗰𝗮𝗿𝗲. Visit https://lnkd.in/dUV4CUxt 🌍 #WoundCare #HealthcareInnovation #BiofilmRemoval #DEBRICHEM #HealingSolutions #DEBxMedical

Next week, we’re excited to join the 𝟭𝟴𝘁𝗵 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝘂𝗻𝗱𝘀 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗶𝗻 𝗔𝗻𝘁𝗮𝗹𝘆𝗮, 𝗧𝘂𝗿𝗸𝗲𝘆! Taking place in collaboration with the 𝟭𝟬𝘁𝗵 𝗞𝗶𝗻𝗴'𝘀 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗗𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗙𝗼𝗼𝘁 𝗥𝗲𝗰𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝗶𝗼𝗻 from November 14-17, this event brings together top KOLs from both Turkey and the United Kingdom to share the latest advancements in treatment practices. We’ll be at the conference with our distributor, Ditanova, where you can find us at booth 36/38/39 to learn more about our unique approach to wound care with DEBRICHEM®. We’re also hosting a symposium: 🗓 𝗗𝗮𝘁𝗲: November 16 🕒 𝗧𝗶𝗺𝗲: 13:50 - 14:20 📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Hall B 📜 𝗧𝗶𝘁𝗹𝗲: A Novel, One-Time Topical Desiccating Agent for Chemical Debridement 👨⚕️ 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗱 𝗯𝘆: Dr. Alberto Cogo and Dr. H. Erhan Güven This session will dive into the mode of action of DEBRICHEM® and its versatility across different wound etiologies. Dr. Erhan will also present Turkish evidence on the use of DEBRICHEM® in managing acute diabetic foot infections, offering valuable insights for clinicians treating complex cases. If you’re attending the conference, schedule a meeting with our team via info@debx-medical.com or pass by our booth to learn more about our solution, and how we’re addressing one of the biggest challenges in wound care. We look forward to seeing you there! #DEBRICHEM #Debridement #DEBxMedical #biofilm #woundhealing

🌟 𝗠𝗮𝘀𝘁𝗲𝗿 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗗𝗲𝗯𝗿𝗶𝗱𝗲𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗗𝗘𝗕𝘅 𝗠𝗲𝗱𝗶𝗰𝗮𝗹'𝘀 𝗠𝗮𝗱𝗲 𝗘𝗮𝘀𝘆 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗮𝘁 𝗪𝗼𝘂𝗻𝗱𝘀 𝗨𝗞 𝟮𝟬𝟮𝟰! 🌟 Dr. Steven Jeffery, Professor of Wound Study and Medical Director at Pioneer Wound Healing and Lymphoedema Centres will lead our 𝗠𝗮𝗱𝗲 𝗘𝗮𝘀𝘆 𝗦𝗲𝘀𝘀𝗶𝗼𝗻: 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝘁𝗼 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗗𝗲𝗯𝗿𝗶𝗱𝗲𝗺𝗲𝗻𝘁 at Wounds UK 2024! 🌟 Join us in Harrogate on November 11th for this interactive workshop, where you’ll gain valuable insights into: 💡 The fundamentals of chemical debridement. 💡 The mode of action of DEBRICHEM® and its integration into existing treatment protocols. 💡 Identifying suitable patients and wound types to optimize healing outcomes. 💡 Hands-on skills development for effective chemical debridement techniques. Our session runs twice during the conference, offering a unique opportunity to >100 clinicians to broaden their understanding and enhance their practical skills in wound care. 👉 Questions? Reach out to us at info@debx-medical.com. 👉 Follow DEBx Medical on LinkedIn for updates and insights from the session and the event. We look forward to connecting with you at Wounds UK 2024! #WoundsUK2024 #WoundCare #HealthcareInnovation #DEBxMedical #DEBRICHEM

🚨 𝗟𝗮𝘀𝘁 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝗷𝗼𝗶𝗻 𝘂𝘀 𝘁𝗼𝗱𝗮𝘆 𝗮𝘁 𝟭𝟱:𝟬𝟬 𝗖𝗘𝗧 𝗳𝗼𝗿 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠®! We’ll be diving into how DEBRICHEM® targets biofilm without harming healthy tissue, a key topic in wound care. Don’t miss this opportunity to learn directly how to implement this treatment in your own clinical practice. ⏰ There’s still time to register—sign up now and gain valuable insights into advanced wound care practices! 👉 𝗦𝗶𝗴𝗻 𝘂𝗽 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝘃𝗶𝗮 𝘁𝗵𝗲 𝗹𝗶𝗻𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀!

🌟 This week, we had the opportunity to present at the 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 at Erasmus MC in the Netherlands, on Monday, 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟰, 𝟮𝟬𝟮𝟰. The event focused on 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗶𝗻 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗦𝘂𝗿𝗴𝗲𝗿𝘆 and gathered an expert audience of physicians, researchers, and nurses. 🗣️ DEBx Medical 's Product and Clinical Director, Hans-Pieter Snels, delivered an insightful introduction to 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗗𝗲𝗯𝗿𝗶𝗱𝗲𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠® and its role in managing infected wounds. DEBRICHEM® is a topical desiccating agent that addresses the biggest challenge in non-healing wounds by effectively removing biofilm and infection, creating a cleaner wound bed and supporting the natural healing process. 🔍 𝗞𝗲𝘆 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 🔷 𝗥𝗮𝗽𝗶𝗱 𝗠𝗼𝗱𝗲 𝗼𝗳 𝗔𝗰𝘁𝗶𝗼𝗻: DEBRICHEM® non-selectively eradicates infection and biofilm in a single, 𝟲𝟬 𝘀𝗲𝗰𝗼𝗻𝗱 treatment. 🔷 𝗦𝗶𝗻𝗴𝗹𝗲 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗦𝘂𝗰𝗰𝗲𝘀𝘀: Over 𝟵𝟬% of cases achieve granulation after just one application, enhancing efficiency in wound care. 🔷 𝗦𝗮𝗳𝗲 𝗳𝗼𝗿 𝗜𝗻𝘁𝗮𝗰𝘁 𝗦𝗸𝗶𝗻: DEBRICHEM® rapidly desiccates the wound bed while protecting surrounding healthy tissue. 🔷 𝗖𝗼𝘀𝘁-𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻: DEBRICHEM® is 𝟱𝟳% more cost-effective than standard wound care, potentially saving millions for healthcare systems. 📍 Thank you to everyone who attended and engaged in this important discussion! 👉 Questions? Reach out to our team via info@debx-medical.com 👉 Follow DEBx Medical on LinkedIn for updates and insights. #WoundCare #DEBRICHEM #VascularSurgery #HealthcareEducation #DEBxMedical #ErasmusMC #Netherlands

Meet an 85-year-old woman from Spain with a complex medical history who had been battling two pressure ulcers for four months. This case highlights the challenges of treating patients with multiple comorbidities and how DEBRICHEM® was able to make a difference in getting the wound to the healing stage. 🔹 𝗛𝗲𝗿 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲: The patient had two ulcers located in the sacral and heel area, both infected and showing significant exudate. The ulcers were painful and slow to heal despite previous treatments. 🔹 𝗛𝗼𝘄 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠® 𝗠𝗮𝗱𝗲 𝗮 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲: DEBRICHEM® was applied to the wounds, which were then covered with moist environment dressings and managed with careful follow-up. 🔹 𝗦𝘁𝗲𝗮𝗱𝘆 𝗛𝗲𝗮𝗹𝗶𝗻𝗴 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀: ✔️ 𝗔𝘁 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻: The wounds were infected and painful, showing minimal signs of healing (Figures A1 and A2). ✔️ 𝟮 𝗪𝗲𝗲𝗸𝘀 𝗣𝗼𝘀𝘁-𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠®: Almost 100% of the wound bed showed granulation tissue, indicating significant healing (Figures B1 and B2). ✔️ 𝗢𝘂𝘁𝗰𝗼𝗺𝗲: Despite the patient’s overall poor health and bronchial aspiration, there was clear progress in the wound bed. Unfortunately, the patient passed away a month and a half after treatment. 📸 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗝𝗼𝘂𝗿𝗻𝗲𝘆: ✔️ 𝗙𝗶𝗴𝘂𝗿𝗲 𝗔𝟭 & 𝗔𝟮: Before DEBRICHEM®. ✔️ 𝗙𝗶𝗴𝘂𝗿𝗲 𝗕𝟭 & 𝗕𝟮: 2 weeks post-DEBRICHEM®. This case shows how DEBRICHEM® promotes rapid granulation tissue formation even in patients with complex conditions, emphasizing its role in treating pressure ulcers effectively. 👏 Let’s celebrate the progress made in this case and continue to explore how DEBRICHEM® is improving patient outcomes. 📌 Follow DEBx Medical for more inspiring case studies and updates. Explore more case studies on our website: https://lnkd.in/dzTcvAD8 🚀 #WoundCare #biofilm #PressureUlcer #HealthcareInnovation #DEBxMedical #DEBRICHEM #CaseStudy

🌟 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗪𝗼𝘂𝗻𝗱 𝗖𝗮𝗿𝗲 𝗮𝘁 𝗪𝗼𝘂𝗻𝗱𝘀 𝗨𝗞 𝟮𝟬𝟮𝟰! 🌟 Join us in Harrogate at Wounds UK 2024! From 11-13th November we will be exhibiting at the conference and host our own educational Made Easy Session in the official program. 🗓 𝗗𝗮𝘁𝗲: November 11-13 📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Harrogate Convention Centre, UK 💡 𝗗𝗘𝗕𝘅 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗠𝗮𝗱𝗲 𝗘𝗮𝘀𝘆 𝗦𝗲𝘀𝘀𝗶𝗼𝗻: Introduction to Chemical Debridement: Preparing the Optimal Wound Bed for Healing Our Made Easy Session features a 45-minute interactive workshop running twice, led by Steven Jeffery, Professor of Wound Study and Medical Director at Pioneer Wound Healing and Lymphoedema Centres. 𝗗𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗮𝗱𝗲 𝗘𝗮𝘀𝘆 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝘄𝗲 𝘄𝗶𝗹𝗹 𝗰𝗼𝘃𝗲𝗿: ‣ The fundamentals of chemical debridement. ‣ The mode of action of DEBRICHEM® and its integration into existing treatment protocols. ‣ Identifying suitable patients and wound types to optimize healing outcomes. ‣ Hands-on skills development for effective chemical debridement techniques. 👉 Don’t miss this chance to elevate your wound care expertise! Register Here: https://lnkd.in/e7hkvBTU We look forward to connecting with you at Wounds UK 2024! 📈 𝗜𝗳 𝘆𝗼𝘂 𝗰𝗮𝗻'𝘁 𝗷𝗼𝗶𝗻 𝗯𝘂𝘁 𝗮𝗿𝗲 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱 𝗶𝗻 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗺𝗼𝗿𝗲, 𝗽𝗹𝗲𝗮𝘀𝗲 𝗰𝗵𝗲𝗰𝗸 𝗼𝘂𝗿 𝘂𝗽𝗰𝗼𝗺𝗶𝗻𝗴 𝗲𝘃𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝘄𝗲𝗯𝗶𝗻𝗮𝗿𝘀, 𝗶𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗴 𝗼𝘂𝗿 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗼𝗻 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟳𝘁𝗵 𝗮𝗯𝗼𝘂𝘁 𝗵𝗼𝘄 𝗮𝗻 𝗔𝗰𝗶𝗱𝗶𝗰 𝗧𝗼𝗽𝗶𝗰𝗮𝗹 𝗗𝗲𝘀𝗶𝗰𝗰𝗮𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁 𝗰𝗮𝗻 𝗵𝗲𝗹𝗽 𝗲𝗹𝗶𝗺𝗶𝗻𝗮𝘁𝗲 𝗯𝗶𝗼𝗳𝗶𝗹𝗺 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗵𝗮𝗿𝗺𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝘆 𝘀𝗸𝗶𝗻. 🔗 JOIN the Webinar Here (offline recording will be available): https://lnkd.in/e_9at75B #WoundsUK2024 #WoundCare #HealthcareInnovation #DEBxMedical #DEBRICHEM #ChronicWounds

🚨 𝗛𝗼𝘄 𝗕𝗹𝗼𝗼𝗱 𝗩𝗲𝘀𝘀𝗲𝗹 𝗗𝗮𝗺𝗮𝗴𝗲 𝗔𝗳𝗳𝗲𝗰𝘁𝘀 𝗪𝗼𝘂𝗻𝗱 𝗛𝗲𝗮𝗹𝗶𝗻𝗴❓ In people with diabetes, damage to small blood vessels (microvasculature) can cause serious problems like thickened capillary walls and the buildup of proteins. This damage then leads to complications in larger blood vessels (macrovasculature), such as atherosclerosis (plaque buildup in arteries). 🔗 Small and large vessel diseases are closely connected. When small vessels are damaged, oxygen levels drop, which can increase the risk of atherosclerosis and affect blood flow. Poor blood flow significantly impacts the body’s ability to heal wounds. Key wound healing processes that are affected: ➡️ 𝗔𝗻𝗴𝗶𝗼𝗴𝗲𝗻𝗲𝘀𝗶𝘀: The formation of new blood vessels that supply oxygen and nutrients to the wound. ➡️ 𝗚𝗿𝗼𝘄𝘁𝗵 𝗙𝗮𝗰𝘁𝗼𝗿𝘀: Essential proteins like VEGF, TGF-β, and PDGF that promote tissue growth and repair. When these processes are disrupted, wound healing slows down or stops entirely. Understanding this connection between small and large blood vessel issues is key to improving care for people with diabetes and supporting better wound healing. 👉 Visit our product page to discover how DEBRICHEM®, a fast-acting chemical debridement agent that works in just 60 seconds, is revolutionizing chronic wound care.: https://lnkd.in/dZTuMHZX. 💬 Have thoughts or questions? Let’s connect! Email us at info@debx-medical.com #WoundCare #DiabetesCare #WoundHealing #DEBRICHEM #HealthcareInnovation #VascularHealth #ChronicWounds

DEBx Medical: Delivering Real Solutions for Wound Healing DEBx Medical are focused on advancing research in biofilm and infection control to transform wound care practices. Their goal is to develop science-backed solutions that address the root causes of healing delays in chronic wounds. See how their research leads to real solutions: https://lnkd.in/e4E3JnRs

⏰ 𝗢𝗻𝗹𝘆 𝗮 𝗳𝗲𝘄 𝗱𝗮𝘆𝘀 𝗹𝗲𝗳𝘁 𝘁𝗼 𝘀𝗶𝗴𝗻 𝘂𝗽! ⏰ Over 𝟯𝟬𝟬 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗵𝗮𝘃𝗲 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿𝗲𝗱 to join our upcoming webinar, where we’ll address one of the most asked questions: How does DEBRICHEM® affect healthy skin? In this 40-minute session, Hans-Pieter Snels, Product and Clinical Director at DEBx Medical will dive into the 𝘀𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝘂𝗻𝗶𝗾𝘂𝗲 𝗺𝗼𝗱𝗲 𝗼𝗳 𝗮𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗗𝗘𝗕𝗥𝗜𝗖𝗛𝗘𝗠®. We’ll discuss how it precisely targets biofilm while preserving healthy tissue—backed by insights from our human explant model study. Don't miss out on this chance to understand the science and clinical advantages behind DEBRICHEM® and how it’s innovating the future of wound care. 👉 Register now to secure your spot: https://lnkd.in/e_9at75B #DEBRICHEM #DEBxMedical #woundcare #biofilm #woundhealing